obesity-995x60.png
FEATURED ARTICLES
Early Patient Education And Community Outreach Are Advancing Representation In Clinical Trials
Merck Executive Director, Clinical Trial Patient Representation, Adrelia Allen argues that patient awareness, access, early information, and trust shape are the pillars of patient representation in clinical trials.
-
![clinical-trials-tech-GettyImages-2224526089]( "Why More Sponsors Are Taking Control Of Clinical Trial Study Builds")
Why More Sponsors Are Taking Control Of Clinical Trial Study BuildsAccelerate study startup and reduce rework by building studies directly in EDC. Discover a more flexible, efficient approach to managing clinical trials and data quality.
-
![woman receiving cancer treatment-GettyImages-1346190289]( "The Promise Of Bispecifics In The Quest For Outpatient Immunotherapy")
The Promise Of Bispecifics In The Quest For Outpatient ImmunotherapySTART San Antonio's Drew Rasco, MD, reflects on the evolution of immunotherapy and highlights how novel therapies such as bispecifics are both challenging and intriguing for principal investigators (PIs).
-
![MRI_forPR_final-(4)-(1)]( "Digital Twins Enhance Disease Progression Measurements In FSHD")
Digital Twins Enhance Disease Progression Measurements In FSHDDigital twins can transform trial design by making data more robust and alleviating patient burden. In this interview, Epicrispr CEO Amber Salzman, Ph.D., shares how the company's using it to reliably predict muscle volume change in their trial for a FSHD gene therapy.
SERVICES AND PRODUCTS
Cardinal Symptom Monitoring for Parkinson's and Huntington's Disease Trials
Continuous, objective tracking of cardinal symptoms in chronic diseases can support a better understanding of disease progression and treatment response.
Rapidly reduced timelines and waste, and the prevention of costly product shortages
In a world that is constantly changing, the development of innovative personalised medicine is helping more of us to live healthier lives for longer. These leaps forward in drug development create new hope for patients.
Yet operating high-value, time-sensitive supply chains naturally brings additional challenge and risk. Challenge and risk that require a step change in production approach to effectively balance patient-centricity with commercial viability.
Almac Trial Coordinator™ is a unified eClinical orchestration solution designed to simplify the execution of complex clinical trials. It brings together core trial functions including Interactive Response Technology (IRT), electronic Clinical Outcome Assessments (eCOA), eConsent, visit and participant management, and clinical supply oversight within a single, cohesive ecosystem.
Rather than operating as a collection of disconnected point solutions, Almac Trial Coordinator™ is designed to coordinate workflows, data, and users across the clinical trial lifecycle. The result is a more efficient, transparent, and site-friendly way to run global studies.
Boost patient engagement. Simplify and reduce site workload. Enable real-time, local currency payments through the patient’s preferred method.
Trial Enablement Solutions
Digital health technologies have the potential to transform clinical trials, yet without careful planning and operational support, their implementation can create complexity, increase site burden, and jeopardize data quality.
Backed by over 20 years of experience across nearly 300 industry-sponsored trials, Ametris’ Digital Health Operations team delivers end-to-end trial enablement services to ensure seamless technology deployment, reduce site burden, and capture reliable, high-quality data.
Ensure accurate, compliant, and impactful documentation with Altasciences' experienced medical writers and regulatory experts.